KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Free Cash Flow: 2009-2024

Historic Free Cash Flow for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $808.1 million.

  • Idexx Laboratories' Free Cash Flow rose 93.36% to $371.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $963.6 million, marking a year-over-year increase of 21.57%. This contributed to the annual value of $808.1 million for FY2024, which is 4.55% up from last year.
  • As of FY2024, Idexx Laboratories' Free Cash Flow stood at $808.1 million, which was up 4.55% from $772.9 million recorded in FY2023.
  • Over the past 5 years, Idexx Laboratories' Free Cash Flow peaked at $808.1 million during FY2024, and registered a low of $394.1 million during FY2022.
  • Over the past 3 years, Idexx Laboratories' median Free Cash Flow value was $772.9 million (recorded in 2023), while the average stood at $658.4 million.
  • In the last 5 years, Idexx Laboratories' Free Cash Flow tumbled by 38.03% in 2022 and then soared by 96.09% in 2023.
  • Idexx Laboratories' Free Cash Flow (Yearly) stood at $541.1 million in 2020, then climbed by 17.54% to $636.0 million in 2021, then tumbled by 38.03% to $394.1 million in 2022, then skyrocketed by 96.09% to $772.9 million in 2023, then climbed by 4.55% to $808.1 million in 2024.